Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24910342
Announcement
Collapse
No announcement yet.
O-1663
Collapse
X